SCHEMBL30804420

SCHEMBL30804420

CC1(C)c2ccccc2-c2cc(Nc3ccccc3)ccc21

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDK2 Q15119 4/20 0.51
▸ ALDH1A1 P00352 6/20 0.45
▸ MAPT P10636 5/20 0.45
▸ MEN1 O00255 3/20 0.45
▸ KMT2A Q03164 3/20 0.45
▸ AR P10275 1/20 0.45
▸ APP P05067 1/20 0.45
▸ ALOX12 P18054 5/20 0.45
▸ L3MBTL1 Q9Y468 5/20 0.45
▸ HSD17B10 Q99714 4/20 0.45
▸ TDP1 Q9NUW8 3/20 0.45
▸ TSHR P16473 3/20 0.45
▸ ALOX15 P16050 3/20 0.45
▸ PTGS1 P23219 1/20 0.45
▸ SLC6A2 P23975 1/20 0.45
▸ MAPK1 P28482 1/20 0.45
▸ PTGS2 P35354 1/20 0.45
▸ HTR2B P41595 1/20 0.45
▸ CYP3A4 P08684 4/20 0.43
▸ HPGD P15428 3/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29514944 1.00 PDK2 (0.51) PDK2ALDH1A1MAPTMEN1KMT2A
SCHEMBL25984896 1.00 PDK2 (0.51) PDK2ALDH1A1MAPTMEN1KMT2A
SCHEMBL13443230 1.00 PDK2 (0.51) PDK2ALDH1A1MAPTMEN1KMT2A
SCHEMBL30363346 0.95 PDK2 (0.44) PDK2ALDH1A1MAPTMEN1KMT2A
SCHEMBL13443225 0.95 PDK2 (0.44) PDK2ALDH1A1MAPTMEN1KMT2A
SCHEMBL24055888 0.92 PDK2 (0.44) PDK2ALDH1A1MAPTMEN1KMT2A
SCHEMBL30266582 0.92 PDK2 (0.44) PDK2ALDH1A1MAPTMEN1KMT2A
SCHEMBL14681512 0.92 PDK2 (0.44) PDK2ALDH1A1MAPTMEN1KMT2A
SCHEMBL26574674 0.92 PDK2 (0.48) PDK2ALDH1A1MAPTMEN1KMT2A
SCHEMBL24794291 0.91 PDK2 (0.43) PDK2ALDH1A1MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4519383-B1 CYCLIC COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2026-01-14 — — EP disclosed
US-20250295028-A1 CYCLIC COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2025-09-18 — — US disclosed
CN-118956379-A Organic electroluminescent material containing double main bodies, and preparation method and application thereof 吉林奥来德光电材料股份有限公司 2024-11-15 — — CN disclosed
WO-2024041060-A1 ARYLAMINE COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS 陕西莱特光电材料股份有限公司 2024-02-29 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250295028-A1 CYCLIC COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT DEVICES VDAC2, VDAC3, CYCS PDK2 498/4885ALDH1A1 484/4885MAPT 2021/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback